Retraction of: PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors

No authors listed

No authors listed. Neuro Oncol. 2024.

. 2024 Apr 5;26(4):775.

doi: 10.1093/neuonc/noad081.

No abstract available

Retraction of

PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors.
Ferdosi SR, Taylor B, Lee M, Tang N, Peng S, Bybee R, Reid G, Hartman L, Garcia-Mansfield K, Sharma R, Pirrotte P, Ma J, Parisian AD, Furnari F, Dhruv HD, Berens ME. Ferdosi SR, et al. Neuro Oncol. 2022 Nov 2;24(11):1857-1868. doi: 10.1093/neuonc/noac067. Neuro Oncol. 2022. Retraction in: Neuro Oncol. 2024 Apr 5;26(4):775. doi: 10.1093/neuonc/noad081. PMID: 35305088 Free PMC article. Retracted.
Targeting neddylation in cancer.
Goenka A, Cheng SY. Goenka A, et al. Neuro Oncol. 2022 Nov 2;24(11):1869-1870. doi: 10.1093/neuonc/noac159. Neuro Oncol. 2022. Retraction in: Neuro Oncol. 2024 Apr 5;26(4):775. doi: 10.1093/neuonc/noad081. PMID: 35749751 Free PMC article. Retracted. No abstract available.